tiprankstipranks
MediPharm Labs Reports Strong Financial Growth
Company Announcements

MediPharm Labs Reports Strong Financial Growth

Medipharm Labs (Otc) (TSE:LABS) has released an update.

Don't Miss our Black Friday Offers:

MediPharm Labs Corp. has reported a significant improvement in its 2023 financial performance, with a 50% increase in annual revenue to $33M and a 50% betterment in Adjusted EBITDA, despite it remaining negative at $10M. The company has made strides in the international medical cannabis market, particularly in Brazil and the EU, and anticipates increased sales from new products. Highlighting cost reductions and margin expansions, MediPharm is on a strategic path towards profitability, as evidenced by their positive gross margin shift and reduced operational expenses.

For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskMediPharm Labs Reports Strong Q3 Growth
TheFlyRising High: Cannabis firms report quarterly earnings
TipRanks Canadian Auto-Generated NewsdeskMediPharm Labs Reports Financial Growth and Expansion
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App